Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | CA9 | Q16790 | 3/20 | 0.36 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.36 |
| ▸ | NAAA | Q02083 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1317072 | 1.00 | CES1 (0.48) | CES1CES2MEN1THRBHTT | |
| SCHEMBL1317078 | 1.00 | CES1 (0.48) | CES1CES2MEN1THRBHTT | |
| SCHEMBL1318168 | 1.00 | CES1 (0.48) | CES1CES2MEN1THRBHTT | |
| SCHEMBL2925106 | 0.82 | CES1 (0.47) | CES1CES2MEN1THRBHTT | |
| SCHEMBL341903 | 0.82 | CES1 (0.47) | CES1CES2MEN1THRBHTT | |
| SCHEMBL11220391 | 0.82 | CES1 (0.47) | CES1CES2MEN1THRBHTT | |
| SCHEMBL342032 | 0.82 | CES1 (0.47) | CES1CES2MEN1THRBHTT | |
| SCHEMBL216493 | 0.79 | CES1 (0.44) | CES1CES2MEN1THRBHTT | |
| SCHEMBL11149666 | 0.75 | CES1 (0.57) | CES1CES2MEN1THRBHTT | |
| SCHEMBL4875783 | 0.75 | CES1 (0.57) | CES1CES2MEN1THRBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110269652-A1 | GEMINI SURFACTANTS | ST. FRANCIS XAVIER UNIVERSITY (CA) | 2011-11-03 | — | — | US | disclosed |
| EP-2349978-A1 | GEMINI SURFACTANTS | St. Francis Xavier University (CA) | 2011-08-03 | — | — | EP | disclosed |
| WO-2010048715-A1 | GEMINI SURFACTANTS | ST. FRANCIS XAVIER UNIVERSITY (CA) | 2010-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110269652-A1 | GEMINI SURFACTANTS | SGMS1, DEGS1, GMNN | CES1 103/4885CES2 1196/4885MEN1 1779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.